NCT04467554

Brief Summary

This clinical study is being conducted to evaluate a new training device, the T-CHAIR, for trunk rehabilitation and post-stroke balance. The investigators would like to study three objectives. First, the investigators want to examine whether training with a new training device is feasible and safe during rehabilitation in the later phase, more than six months after a stroke. The investigators also evaluate whether training with a new training device has an effect on the sitting balance and the function and strength of the trunk. Finally, the investigators examine whether training with a new training device has an effect on walking, standing and activities of daily life and self-care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 13, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

July 17, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2021

Completed
Last Updated

January 28, 2022

Status Verified

January 1, 2022

Enrollment Period

5 months

First QC Date

June 29, 2020

Last Update Submit

January 14, 2022

Conditions

Keywords

StrokeRehabilitationChronic phasefeasibilityrandomized controlled trial

Outcome Measures

Primary Outcomes (9)

  • Recruitment

    Recruitment is characterized by the number of possible participants divided by the number of participants actually participated in the trial.

    Through study completion, an average of 1.5 months.

  • Retention

    Retention is the number of participants that complete the whole trial divided by the number of participants that are included in the study.

    Through study completion, an average of 1.5 months.

  • Participation

    During each therapy the therapist evaluates the participation of each candidate.

    Through study completion, an average of 1.5 months.

  • Adherence

    After each therapy session the therapist evaluates the adherence using the Clinician Rating of Compliance Scale. This is a seven point ordinal scale which assesses the level of adherence of the patient. A higher score represent better adherence. A score lower than five is defined as non-adherent.

    Through study completion, an average of 1.5 months.

  • Acceptability and enjoyment

    The level of enjoyment during the training will be assessed using the physical activity enjoyment scale. This scale contains 18 items, during the training participants have to score how they feel about the training on a seven-point bipolar scale. The lowest score stands for less enjoyment or acceptance, a higher score stands for maximum enjoyment or acceptance.

    Through study completion, an average of 1.5 months.

  • Safety and Adverse events

    Safety is evaluated by retaining all adverse events during the therapy sessions.

    Through study completion, an average of 1.5 months.

  • Device development or modifications

    Feedback from the participants and therapists to improve the device are noted after every session. Each patient and therapist who came in contact with the device received an experience questionnaire. The questionnaire contains 16 questions, 3 questions and 13 categorical questions on 5 or 7 point Likert scale.

    Through study completion, an average of 1.5 months.

  • Fatigue

    After each training session fatigue will be evaluated using Visual Analog Fatigue Scale.This scale consists of a 10 cm horizontal line with written description at each end of the line. The written description varies from no fatigue to Very Severe Fatigue on top of the 10 cm line.

    Through study completion, an average of 1.5 months.

  • Patient Global Impression of Change

    The patient Global impression of change is a one single question to rate their condition after the therapy sessions compared to the rate of their condition at the start of the therapy session. This scale will be evaluated twice. One time after two weeks of intervention and once after the four weeks of intervention.

    Through study completion, an average of 1.5 months.

Secondary Outcomes (11)

  • Trunk function

    Through study completion, an average of 1.5 months.

  • Trunk stability

    Through study completion, an average of 1.5 months.

  • Trunk strength

    Through study completion, an average of 1.5 months.

  • Sitting balance

    Through study completion, an average of 1.5 months.

  • Walking speed

    Through study completion, an average of 1.5 months.

  • +6 more secondary outcomes

Study Arms (2)

Measurements and T-chair training

EXPERIMENTAL

This group will receive three measurements sessions and training with a new developed device (15 therapy sessions in total).

Device: T-chair

Measurements

NO INTERVENTION

This group will receive three measurements sessions.

Interventions

T-chairDEVICE

Participants will receive 15 sessions of intervention, four weeks in total with a duration of one hour for each session. The focus of the intervention will be trunk rehabilitation.

Measurements and T-chair training

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First major stroke event, a transient ischemic attack or a previous stroke with full recovery is allowed.
  • Impairment of the trunk function, with a maximum score of 19 on the trunk impairment scale .
  • Able to maintain seated position for more than 10 seconds.
  • Able to come to the rehabilitation ward as a chronic patient.
  • More than six months after a stroke event.
  • Older than 18 years.
  • With no comorbidities other than stroke affecting trunk function. Comorbidities could be musculoskeletal problems or other neurological diseases.
  • With sufficient cognitive and language capacity to perform the assessment.

You may not qualify if:

  • Not able to give informed consent.
  • Not approved informed consent.
  • Subject does not understand the study procedures.
  • Subject has any history of another major neurological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liselot Thijs

Leuven, 3000, Belgium

Location

Related Publications (1)

  • Thijs L, Voets E, Wiskerke E, Nauwelaerts T, Arys Y, Haspeslagh H, Kool J, Bischof P, Bauer C, Lemmens R, Baumgartner D, Verheyden G. Technology-supported sitting balance therapy versus usual care in the chronic stage after stroke: a pilot randomized controlled trial. J Neuroeng Rehabil. 2021 Jul 28;18(1):120. doi: 10.1186/s12984-021-00910-7.

Related Links

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 29, 2020

First Posted

July 13, 2020

Study Start

July 17, 2020

Primary Completion

December 18, 2020

Study Completion

July 13, 2021

Last Updated

January 28, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations